Cholinesterase inhibitor treatment in patients with delirium

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalThe Lancet
Volume377
Issue number9769
Pages (from-to)900; author reply 901
ISSN0140-6736
DOIs
Publication statusPublished - 12 Mar 2011

    Research areas

  • Aged, Cholinesterase Inhibitors/adverse effects, Critical Illness, Delirium/complications, Humans, Intensive Care Units, Phenylcarbamates/adverse effects, Rivastigmine, Sepsis/complications

ID: 236994009